Skip to main content
Erschienen in: Journal of Interventional Cardiac Electrophysiology 1/2018

03.03.2018

Subcutaneous implantable cardioverter defibrillator eligibility according to a novel automated screening tool and agreement with the standard manual electrocardiographic morphology tool

verfasst von: Pietro Francia, Matteo Ziacchi, Paolo De Filippo, Stefano Viani, Antonio D’Onofrio, Vincenzo Russo, Carmen Adduci, Mauro Biffi, Paola Ferrari, Valter Bianchi, Ernesto Ammendola, Francesca Palano, Jessica Frisoni, Sergio Valsecchi, Mariolina Lovecchio, Maria Grazia Bongiorni

Erschienen in: Journal of Interventional Cardiac Electrophysiology | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Since subcutaneous implantable cardioverter defibrillator (S-ICD) introduction, the pre-implant screening based on a dedicated manual ECG tool (MST) was required to assure adequate sensing by the S-ICD. A novel automated screening tool (AST) has been recently developed. We assessed and compared the pass rate with AST and MST, and we measured the agreement between screening tools.

Methods

Three electrodes were positioned at locations mimicking the placement of the S-ICD, and ECG recordings were collected in the supine and standing postures at rest. The three sensing vectors were analyzed with the MST and the AST. Eligibility was defined by the presence of at least one or two appropriate vectors in both postures.

Results

A total of 235 patients with an indication to ICD and no need for permanent pacing were enrolled. At least one suitable vector was identified in 214 (91%) patients with MST and 221 (94%) patients with AST (p = 0.219). At least two vectors were appropriate in 162 (69%) patients with MST and 187 (80%) patients with AST (p = 0.008). Overall, out of 1587 ECG analyzed, 1035 (65%) qualifying leads were identified with MST and 1111 (70%) with AST (p = 0.004). The agreement between the results of MST and AST ECG analysis was moderate (Kappa = 0.570; standard error = 0.022; CI = 0.526–0.613). The results were consistent regardless of the underlying cardiomyopathy. The most frequent reason for screening failure with MST was a high-amplitude T-wave (31% of failures). With AST, 23% of recordings that failed with MST for high-amplitude T-wave were classified as acceptable.

Conclusion

The AST is associated with higher pass rate than the standard MST. It seems more tolerant of high-amplitude T-waves. Consequently, the agreement between MST and AST findings was only moderate.
Literatur
1.
Zurück zum Zitat Priori SG, Blomström-Lundqvist C, Mazzanti A, Blom N, Borggrefe M, Camm J, Elliott PM, Fitzsimons D, Hatala R, Hindricks G, Kirchhof P, Kjeldsen K, Kuck KH, Hernandez-Madrid A, Nikolaou N, Norekvål TM, Spaulding C, Van Veldhuisen DJ; Task Force for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death of the European Society of Cardiology (ESC). 2015 ESC guidelines for the Management of Patients with ventricular arrhythmias and the prevention of sudden cardiac death: the task force for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death of the European Society of Cardiology (ESC) endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Europace 2015; 17:1601–87. Priori SG, Blomström-Lundqvist C, Mazzanti A, Blom N, Borggrefe M, Camm J, Elliott PM, Fitzsimons D, Hatala R, Hindricks G, Kirchhof P, Kjeldsen K, Kuck KH, Hernandez-Madrid A, Nikolaou N, Norekvål TM, Spaulding C, Van Veldhuisen DJ; Task Force for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death of the European Society of Cardiology (ESC). 2015 ESC guidelines for the Management of Patients with ventricular arrhythmias and the prevention of sudden cardiac death: the task force for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death of the European Society of Cardiology (ESC) endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Europace 2015; 17:1601–87.
2.
Zurück zum Zitat Weiss R, Knight BP, Gold MR, Leon AR, Herre JM, Hood M, et al. Safety and efficacy of a totally subcutaneous implantable-cardioverter defibrillator. Circulation. 2013;128:944–53.CrossRefPubMed Weiss R, Knight BP, Gold MR, Leon AR, Herre JM, Hood M, et al. Safety and efficacy of a totally subcutaneous implantable-cardioverter defibrillator. Circulation. 2013;128:944–53.CrossRefPubMed
3.
Zurück zum Zitat Lee DS, Krahn AD, Healey JS, Birnie D, Crystal E, Dorian P, et al. Investigators of the Ontario ICD database.. Evaluation of early complications related to de novo cardioverter defibrillator implantation insights from the Ontario ICD database. J Am Coll Cardiol. 2010;55:774–82.CrossRefPubMed Lee DS, Krahn AD, Healey JS, Birnie D, Crystal E, Dorian P, et al. Investigators of the Ontario ICD database.. Evaluation of early complications related to de novo cardioverter defibrillator implantation insights from the Ontario ICD database. J Am Coll Cardiol. 2010;55:774–82.CrossRefPubMed
4.
Zurück zum Zitat Zeb M, Curzen N, Allavatam V, Wilson D, Yue A, Roberts P, et al. Sensitivity and specificity of the subcutaneous implantable cardioverter defibrillator pre-implant screening tool. Int J Cardiol. 2015;195:205–9.CrossRefPubMed Zeb M, Curzen N, Allavatam V, Wilson D, Yue A, Roberts P, et al. Sensitivity and specificity of the subcutaneous implantable cardioverter defibrillator pre-implant screening tool. Int J Cardiol. 2015;195:205–9.CrossRefPubMed
5.
Zurück zum Zitat Brouwer TF, Kooiman KM, Olde Nordkamp LR, van Halm VP, Knops RE. Algorithm-based screening may improve patient selection for the subcutaneous implantable defibrillator. JACC: Clinical Electrophysiology. 2016;2:605–14. Brouwer TF, Kooiman KM, Olde Nordkamp LR, van Halm VP, Knops RE. Algorithm-based screening may improve patient selection for the subcutaneous implantable defibrillator. JACC: Clinical Electrophysiology. 2016;2:605–14.
6.
Zurück zum Zitat Olde Nordkamp LR, Warnaars JL, Kooiman KM, de Groot JR, Rosenmöller BR, Wilde AA, et al. Which patients are not suitable for a subcutaneous ICD: incidence and predictors of failed QRS-T-wave morphology screening. J Cardiovasc Electrophysiol. 2014;25:494–9.CrossRefPubMed Olde Nordkamp LR, Warnaars JL, Kooiman KM, de Groot JR, Rosenmöller BR, Wilde AA, et al. Which patients are not suitable for a subcutaneous ICD: incidence and predictors of failed QRS-T-wave morphology screening. J Cardiovasc Electrophysiol. 2014;25:494–9.CrossRefPubMed
7.
Zurück zum Zitat Randles DA, Hawkins NM, Shaw M, Patwala AY, Pettit SJ, Wright DJ. How many patients fulfil the surface electrocardiogram criteria for subcutaneous implantable cardioverter-defibrillator implantation? Europace. 2014;16:1015–21.CrossRefPubMed Randles DA, Hawkins NM, Shaw M, Patwala AY, Pettit SJ, Wright DJ. How many patients fulfil the surface electrocardiogram criteria for subcutaneous implantable cardioverter-defibrillator implantation? Europace. 2014;16:1015–21.CrossRefPubMed
8.
Zurück zum Zitat Groh CA, Sharma S, Pelchovitz DJ, Bhave PD, Rhyner J, Verma N, et al. Use of an electrocardiographic screening tool to determine candidacy for a subcutaneous implantable cardioverter-defibrillator. Heart Rhythm. 2014;11:1361–6.CrossRefPubMed Groh CA, Sharma S, Pelchovitz DJ, Bhave PD, Rhyner J, Verma N, et al. Use of an electrocardiographic screening tool to determine candidacy for a subcutaneous implantable cardioverter-defibrillator. Heart Rhythm. 2014;11:1361–6.CrossRefPubMed
9.
Zurück zum Zitat Ziacchi M, Corzani A, Diemberger I, Martignani C, Marziali A, Mazzotti A, et al. Electrocardiographic eligibility for subcutaneous implantable cardioverter defibrillator: evaluation during bicycle exercise. Heart Lung Circ. 2016;25:476–83.CrossRefPubMed Ziacchi M, Corzani A, Diemberger I, Martignani C, Marziali A, Mazzotti A, et al. Electrocardiographic eligibility for subcutaneous implantable cardioverter defibrillator: evaluation during bicycle exercise. Heart Lung Circ. 2016;25:476–83.CrossRefPubMed
10.
Zurück zum Zitat Okamura H, McLeod CJ, DeSimone CV, Webster TL, Bonnichsen CR, Grogan M, et al. Right parasternal lead placement increases eligibility for subcutaneous implantable cardioverter defibrillator therapy in adults with congenital heart disease. Circ J. 2016;80:1328–35.CrossRefPubMed Okamura H, McLeod CJ, DeSimone CV, Webster TL, Bonnichsen CR, Grogan M, et al. Right parasternal lead placement increases eligibility for subcutaneous implantable cardioverter defibrillator therapy in adults with congenital heart disease. Circ J. 2016;80:1328–35.CrossRefPubMed
11.
Zurück zum Zitat Wilson DG, Zeb M, Veldtman G, Dimitrov BD, Morgan JM. Left and right parasternal sensing for the S-ICD in adult congenital heart disease patients and normal controls. Pacing Clin Electrophysiol. 2016;39:282–90.CrossRefPubMed Wilson DG, Zeb M, Veldtman G, Dimitrov BD, Morgan JM. Left and right parasternal sensing for the S-ICD in adult congenital heart disease patients and normal controls. Pacing Clin Electrophysiol. 2016;39:282–90.CrossRefPubMed
12.
Zurück zum Zitat Francia P, Adduci C, Palano F, Semprini L, Serdoz A, Montesanti D, et al. Eligibility for the subcutaneous implantable cardioverter-defibrillator in patients with hypertrophic cardiomyopathy. J Cardiovasc Electrophysiol. 2015;26:893–9.CrossRefPubMed Francia P, Adduci C, Palano F, Semprini L, Serdoz A, Montesanti D, et al. Eligibility for the subcutaneous implantable cardioverter-defibrillator in patients with hypertrophic cardiomyopathy. J Cardiovasc Electrophysiol. 2015;26:893–9.CrossRefPubMed
13.
Zurück zum Zitat Maurizi N, Olivotto I, Olde Nordkamp LR, Baldini K, Fumagalli C, Brouwer TF, et al. Prevalence of subcutaneous implantable cardioverter-defibrillator candidacy based on template ECG screening in patients with hypertrophic cardiomyopathy. Heart Rhythm. 2016;13:457–63.CrossRefPubMed Maurizi N, Olivotto I, Olde Nordkamp LR, Baldini K, Fumagalli C, Brouwer TF, et al. Prevalence of subcutaneous implantable cardioverter-defibrillator candidacy based on template ECG screening in patients with hypertrophic cardiomyopathy. Heart Rhythm. 2016;13:457–63.CrossRefPubMed
14.
Zurück zum Zitat Srinivasan NT, Patel KH, Qamar K, Taylor A, Bacà M, Providência R, Tome-Esteban M, Elliott PM, Lambiase PD. Disease severity and exercise testing reduce subcutaneous implantable cardioverter-defibrillator left sternal ECG screening success in hypertrophic cardiomyopathy. Circ Arrhythm Electrophysiol. 2017;10(4). https://doi.org/10.1161/CIRCEP.117.004801. Srinivasan NT, Patel KH, Qamar K, Taylor A, Bacà M, Providência R, Tome-Esteban M, Elliott PM, Lambiase PD. Disease severity and exercise testing reduce subcutaneous implantable cardioverter-defibrillator left sternal ECG screening success in hypertrophic cardiomyopathy. Circ Arrhythm Electrophysiol. 2017;10(4). https://​doi.​org/​10.​1161/​CIRCEP.​117.​004801.
15.
Zurück zum Zitat Santini L, Pappalardo A, Schirripa V, Danisi N, Forleo GB, Ammirati F. Oversensing of an unexpected atrial flutter. A new tool to improve detection of supraventricular arrhythmias in subcutaneous implantable cardioverter-defibrillators. Heart Rhythm Case Rep. 2017;3:286–8.CrossRef Santini L, Pappalardo A, Schirripa V, Danisi N, Forleo GB, Ammirati F. Oversensing of an unexpected atrial flutter. A new tool to improve detection of supraventricular arrhythmias in subcutaneous implantable cardioverter-defibrillators. Heart Rhythm Case Rep. 2017;3:286–8.CrossRef
Metadaten
Titel
Subcutaneous implantable cardioverter defibrillator eligibility according to a novel automated screening tool and agreement with the standard manual electrocardiographic morphology tool
verfasst von
Pietro Francia
Matteo Ziacchi
Paolo De Filippo
Stefano Viani
Antonio D’Onofrio
Vincenzo Russo
Carmen Adduci
Mauro Biffi
Paola Ferrari
Valter Bianchi
Ernesto Ammendola
Francesca Palano
Jessica Frisoni
Sergio Valsecchi
Mariolina Lovecchio
Maria Grazia Bongiorni
Publikationsdatum
03.03.2018
Verlag
Springer US
Erschienen in
Journal of Interventional Cardiac Electrophysiology / Ausgabe 1/2018
Print ISSN: 1383-875X
Elektronische ISSN: 1572-8595
DOI
https://doi.org/10.1007/s10840-018-0326-2

Weitere Artikel der Ausgabe 1/2018

Journal of Interventional Cardiac Electrophysiology 1/2018 Zur Ausgabe

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Strenge Blutdruckeinstellung lohnt auch im Alter noch

30.04.2024 Arterielle Hypertonie Nachrichten

Ältere Frauen, die von chronischen Erkrankungen weitgehend verschont sind, haben offenbar die besten Chancen, ihren 90. Geburtstag zu erleben, wenn ihr systolischer Blutdruck < 130 mmHg liegt. Das scheint selbst für 80-Jährige noch zu gelten.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Dihydropyridin-Kalziumantagonisten können auf die Nieren gehen

30.04.2024 Hypertonie Nachrichten

Im Vergleich zu anderen Blutdrucksenkern sind Kalziumantagonisten vom Diyhdropyridin-Typ mit einem erhöhten Risiko für eine Mikroalbuminurie und in Abwesenheit eines RAS-Blockers auch für ein terminales Nierenversagen verbunden.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.